Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Lou Gehrigs Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lou Gehrigs Diseasemarket, defines the market attractiveness level of Lou Gehrigs Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lou Gehrigs Disease industry, describes the types of Lou Gehrigs Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lou Gehrigs Disease market and the development prospects and opportunities of Lou Gehrigs Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lou Gehrigs Disease market in Chapter 13.
By Player:
Eisai Co Ltd
Avicena Group
Neuraltus Pharmaceuticals Inc
Q-Therapeutics Inc
Neuralstem Inc
Nutra Pharma Corp
Covis Pharmaceutical Inc
Biogen
Ionis Pharmaceuticals, Inc
Pharnext SAS
Mitsubishi Tanabe Pharma Corp
AB Science
BrainStorm Therapeutics
GlaxoSmithKline plc
Cytokinetics Inc
Newron Pharmaceuticals SpA
By Type:
Riluzole
Edaravone (Radicava)
By End-User:
Hospital Pharmacies
Retail & Online Pharmacie
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lou Gehrigs Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lou Gehrigs Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lou Gehrigs Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lou Gehrigs Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lou Gehrigs Disease Market Analysis and Outlook to 2022
-
7.1 Global Lou Gehrigs Disease Consumption (2017-2022)
-
7.2 United States Lou Gehrigs Disease Consumption (2017-2022)
-
7.3 Europe Lou Gehrigs Disease Consumption (2017-2022)
-
7.4 China Lou Gehrigs Disease Consumption (2017-2022)
-
7.5 Japan Lou Gehrigs Disease Consumption (2017-2022)
-
7.6 India Lou Gehrigs Disease Consumption (2017-2022)
-
7.7 South Korea Lou Gehrigs Disease Consumption (2017-2022)
8 Region and Country-wise Lou Gehrigs Disease Market Analysis and Outlook to 2028
-
8.1 Global Lou Gehrigs Disease Consumption Forecast (2022-2028)
-
8.2 United States Lou Gehrigs Disease Consumption Forecast (2022-2028)
-
8.3 Europe Lou Gehrigs Disease Consumption Forecast (2022-2028)
-
8.4 China Lou Gehrigs Disease Consumption Forecast (2022-2028)
-
8.5 Japan Lou Gehrigs Disease Consumption Forecast (2022-2028)
-
8.6 India Lou Gehrigs Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Lou Gehrigs Disease Consumption Forecast (2022-2028)
9 Global Lou Gehrigs Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Lou Gehrigs Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Riluzole Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Edaravone (Radicava) Consumption and Growth Rate (2017-2022)
-
9.2 Global Lou Gehrigs Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail & Online Pharmacie Consumption and Growth Rate (2017-2022)
10 Global Lou Gehrigs Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Lou Gehrigs Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Riluzole Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Edaravone (Radicava) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lou Gehrigs Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail & Online Pharmacie Consumption Forecast and Growth Rate (2022-2028)
11 Global Lou Gehrigs Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lou Gehrigs Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lou Gehrigs Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lou Gehrigs Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lou Gehrigs Disease Market Competitive Analysis
-
14.1 Eisai Co Ltd
-
14.1.1 Eisai Co Ltd Company Details
-
14.1.2 Eisai Co Ltd Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eisai Co Ltd Lou Gehrigs Disease Product and Service
-
14.2 Avicena Group
-
14.2.1 Avicena Group Company Details
-
14.2.2 Avicena Group Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Avicena Group Lou Gehrigs Disease Product and Service
-
14.3 Neuraltus Pharmaceuticals Inc
-
14.3.1 Neuraltus Pharmaceuticals Inc Company Details
-
14.3.2 Neuraltus Pharmaceuticals Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Neuraltus Pharmaceuticals Inc Lou Gehrigs Disease Product and Service
-
14.4 Q-Therapeutics Inc
-
14.4.1 Q-Therapeutics Inc Company Details
-
14.4.2 Q-Therapeutics Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Q-Therapeutics Inc Lou Gehrigs Disease Product and Service
-
14.5 Neuralstem Inc
-
14.5.1 Neuralstem Inc Company Details
-
14.5.2 Neuralstem Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Neuralstem Inc Lou Gehrigs Disease Product and Service
-
14.6 Nutra Pharma Corp
-
14.6.1 Nutra Pharma Corp Company Details
-
14.6.2 Nutra Pharma Corp Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Nutra Pharma Corp Lou Gehrigs Disease Product and Service
-
14.7 Covis Pharmaceutical Inc
-
14.7.1 Covis Pharmaceutical Inc Company Details
-
14.7.2 Covis Pharmaceutical Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Covis Pharmaceutical Inc Lou Gehrigs Disease Product and Service
-
14.8 Biogen
-
14.8.1 Biogen Company Details
-
14.8.2 Biogen Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biogen Lou Gehrigs Disease Product and Service
-
14.9 Ionis Pharmaceuticals, Inc
-
14.9.1 Ionis Pharmaceuticals, Inc Company Details
-
14.9.2 Ionis Pharmaceuticals, Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Ionis Pharmaceuticals, Inc Lou Gehrigs Disease Product and Service
-
14.10 Pharnext SAS
-
14.10.1 Pharnext SAS Company Details
-
14.10.2 Pharnext SAS Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pharnext SAS Lou Gehrigs Disease Product and Service
-
14.11 Mitsubishi Tanabe Pharma Corp
-
14.11.1 Mitsubishi Tanabe Pharma Corp Company Details
-
14.11.2 Mitsubishi Tanabe Pharma Corp Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Mitsubishi Tanabe Pharma Corp Lou Gehrigs Disease Product and Service
-
14.12 AB Science
-
14.12.1 AB Science Company Details
-
14.12.2 AB Science Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 AB Science Lou Gehrigs Disease Product and Service
-
14.13 BrainStorm Therapeutics
-
14.13.1 BrainStorm Therapeutics Company Details
-
14.13.2 BrainStorm Therapeutics Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 BrainStorm Therapeutics Lou Gehrigs Disease Product and Service
-
14.14 GlaxoSmithKline plc
-
14.14.1 GlaxoSmithKline plc Company Details
-
14.14.2 GlaxoSmithKline plc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 GlaxoSmithKline plc Lou Gehrigs Disease Product and Service
-
14.15 Cytokinetics Inc
-
14.15.1 Cytokinetics Inc Company Details
-
14.15.2 Cytokinetics Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Cytokinetics Inc Lou Gehrigs Disease Product and Service
-
14.16 Newron Pharmaceuticals SpA
-
14.16.1 Newron Pharmaceuticals SpA Company Details
-
14.16.2 Newron Pharmaceuticals SpA Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Newron Pharmaceuticals SpA Lou Gehrigs Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lou Gehrigs Disease
-
Figure Lou Gehrigs Disease Picture
-
Table Global Lou Gehrigs Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lou Gehrigs Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lou Gehrigs Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lou Gehrigs Disease Consumption by Country (2017-2022)
-
Figure United States Lou Gehrigs Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Lou Gehrigs Disease Consumption and Growth Rate (2017-2022)
-
Figure China Lou Gehrigs Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Lou Gehrigs Disease Consumption and Growth Rate (2017-2022)
-
Figure India Lou Gehrigs Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lou Gehrigs Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Lou Gehrigs Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Lou Gehrigs Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lou Gehrigs Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lou Gehrigs Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lou Gehrigs Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lou Gehrigs Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lou Gehrigs Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Riluzole Consumption and Growth Rate (2017-2022)
-
Figure Global Edaravone (Radicava) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail & Online Pharmacie Consumption and Growth Rate (2017-2022)
-
Figure Global Riluzole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Edaravone (Radicava) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail & Online Pharmacie Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lou Gehrigs Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lou Gehrigs Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table Eisai Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Eisai Co Ltd Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co Ltd Lou Gehrigs Disease Product and Service
-
Table Avicena Group (Foundation Year, Company Profile and etc.)
-
Table Avicena Group Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avicena Group Lou Gehrigs Disease Product and Service
-
Table Neuraltus Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Neuraltus Pharmaceuticals Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neuraltus Pharmaceuticals Inc Lou Gehrigs Disease Product and Service
-
Table Q-Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Q-Therapeutics Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Q-Therapeutics Inc Lou Gehrigs Disease Product and Service
-
Table Neuralstem Inc (Foundation Year, Company Profile and etc.)
-
Table Neuralstem Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neuralstem Inc Lou Gehrigs Disease Product and Service
-
Table Nutra Pharma Corp (Foundation Year, Company Profile and etc.)
-
Table Nutra Pharma Corp Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nutra Pharma Corp Lou Gehrigs Disease Product and Service
-
Table Covis Pharmaceutical Inc (Foundation Year, Company Profile and etc.)
-
Table Covis Pharmaceutical Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Covis Pharmaceutical Inc Lou Gehrigs Disease Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Lou Gehrigs Disease Product and Service
-
Table Ionis Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Ionis Pharmaceuticals, Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ionis Pharmaceuticals, Inc Lou Gehrigs Disease Product and Service
-
Table Pharnext SAS (Foundation Year, Company Profile and etc.)
-
Table Pharnext SAS Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharnext SAS Lou Gehrigs Disease Product and Service
-
Table Mitsubishi Tanabe Pharma Corp (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Pharma Corp Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Pharma Corp Lou Gehrigs Disease Product and Service
-
Table AB Science (Foundation Year, Company Profile and etc.)
-
Table AB Science Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table AB Science Lou Gehrigs Disease Product and Service
-
Table BrainStorm Therapeutics (Foundation Year, Company Profile and etc.)
-
Table BrainStorm Therapeutics Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table BrainStorm Therapeutics Lou Gehrigs Disease Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Lou Gehrigs Disease Product and Service
-
Table Cytokinetics Inc (Foundation Year, Company Profile and etc.)
-
Table Cytokinetics Inc Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytokinetics Inc Lou Gehrigs Disease Product and Service
-
Table Newron Pharmaceuticals SpA (Foundation Year, Company Profile and etc.)
-
Table Newron Pharmaceuticals SpA Lou Gehrigs Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Newron Pharmaceuticals SpA Lou Gehrigs Disease Product and Service
-
